Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

Human health

Loading...
Global Plan to End TB cost of inaction

Improved diagnostics priority in Global Plan to End TB

November 21, 2022
The Global Plan to End TB is a costed public health plan. It aims to cut deaths by 90% in 8 years. A key recommendation of the report is to universally replace sputum microscopy with rapid molecular diagnostics.
Global Plan to End TB cost of inaction

Improved diagnostics priority in Global Plan to End TB

November 21, 2022
The Global Plan to End TB is a costed public health plan. It aims to cut deaths by 90% in...
Pictured from left are Ray Harris from Foresight, Sandy Reid of Mercia Asset Management, Jane Theaker of PBD Biotech and Mark Wilcockson of British Business Bank

PBD Biotech raises further £2.4m for its breakthrough tuberculosis blood test

October 17, 2022
Human tuberculosis is second only to Covid as the world’s most fatal infectious disease. PBD Biotech has developed a diagnostic with potential to revolutionise management of TB.
Pictured from left are Ray Harris from Foresight, Sandy Reid of Mercia Asset Management, Jane Theaker of PBD Biotech and Mark Wilcockson of British Business Bank

PBD Biotech raises further £2.4m for its breakthrough tuberculosis blood test

October 17, 2022
Human tuberculosis is second only to Covid as the world’s most fatal infectious disease. PBD Biotech has developed a diagnostic...
Rapid Research in Diagnostics Development for TB Network R2D2 TB Network

Promising TB diagnostic Actiphage selected for evaluation by R2D2 TB Network

September 30, 2022
Ease of use at the point of need is vital for the roll out of a diagnostic, so PBD Biotech, developers of Actiphage - a rapid blood test for early-stage tuberculosis - is partnering with the Rapid Research in Diagnostics...
Rapid Research in Diagnostics Development for TB Network R2D2 TB Network

Promising TB diagnostic Actiphage selected for evaluation by R2D2 TB Network

September 30, 2022
Ease of use at the point of need is vital for the roll out of a diagnostic, so PBD Biotech,...
ECCMID

Actiphage TB diagnostic finds live mycobacterium tuberculosis in the blood of people with incipient TB

April 23, 2022
A clinical trial of Actiphage, a promising new diagnostic for tuberculosis infection, has shown for the first time that live bacteria can be detected in the blood of people with incipient TB infection.
ECCMID

Actiphage TB diagnostic finds live mycobacterium tuberculosis in the blood of people with incipient TB

April 23, 2022
A clinical trial of Actiphage, a promising new diagnostic for tuberculosis infection, has shown for the first time that live...
rapid TB test World TB Day - Zambart image

Could Actiphage provide rapid TB test in sub-Saharan Africa?

March 23, 2022
Sub-Saharan Africa is devastated by TB disease. Zambia, has a high TB/HIV burden – 59,000 people developed TB in 2020 and 15,000 died. There is a critical need for a non-sputum based rapid test for diagnosing TB disease.
rapid TB test World TB Day - Zambart image

Could Actiphage provide rapid TB test in sub-Saharan Africa?

March 23, 2022
Sub-Saharan Africa is devastated by TB disease. Zambia, has a high TB/HIV burden – 59,000 people developed TB in 2020...

Human TB study into new blood test achieves funding following successful proof of concept

December 27, 2019
Worldwide a quarter of a million children die of tuberculosis (TB) each year, early diagnosis would help to save their lives but most are unable to produce the sample of mucus that is needed for the current test.

Human TB study into new blood test achieves funding following successful proof of concept

December 27, 2019
Worldwide a quarter of a million children die of tuberculosis (TB) each year, early diagnosis would help to save their...

Rapid blood test offers new hope for people most at risk of TB

July 10, 2019
Tuberculosis (TB) is the leading cause of death from an infectious disease. Although a quarter of the world’s population is thought to carry latent TB, it carries a risk of progressing to the active form of TB in around 10%...

Rapid blood test offers new hope for people most at risk of TB

July 10, 2019
Tuberculosis (TB) is the leading cause of death from an infectious disease. Although a quarter of the world’s population is...

Actiphage blood test could be ‘game changing’ for human TB

May 21, 2019
Tuberculosis (TB) is the leading cause of death from an infectious disease. Although a quarter of the world’s population is thought to carry latent TB, it only progresses to active disease in around 10% of those infected. The reasons for...

Actiphage blood test could be ‘game changing’ for human TB

May 21, 2019
Tuberculosis (TB) is the leading cause of death from an infectious disease. Although a quarter of the world’s population is...
Blood test

New Actiphage test enters human TB trials

March 6, 2019
A new blood test for tuberculosis (TB) could, for the first time, enable screening of patients at an early stage of infection.
Blood test

New Actiphage test enters human TB trials

March 6, 2019
A new blood test for tuberculosis (TB) could, for the first time, enable screening of patients at an early stage...

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More